BRCA1 and BRCA2 - update and implications on the genetics of breast cancer: a clinical perspective - PubMed (original) (raw)
Review
doi: 10.1111/cge.12291. Epub 2013 Oct 25.
Affiliations
- PMID: 24116874
- DOI: 10.1111/cge.12291
Review
BRCA1 and BRCA2 - update and implications on the genetics of breast cancer: a clinical perspective
W D Foulkes. Clin Genet. 2014 Jan.
Erratum in
- Clin Genet. 2014 Mar;85(3):302
No abstract available
Similar articles
- Phenotypic expression of double heterozygosity for BRCA1 and BRCA2 germline mutations.
Leegte B, van der Hout AH, Deffenbaugh AM, Bakker MK, Mulder IM, ten Berge A, Leenders EP, Wesseling J, de Hullu J, Hoogerbrugge N, Ligtenberg MJ, Ardern-Jones A, Bancroft E, Salmon A, Barwell J, Eeles R, Oosterwijk JC. Leegte B, et al. J Med Genet. 2005 Mar;42(3):e20. doi: 10.1136/jmg.2004.027243. J Med Genet. 2005. PMID: 15744030 Free PMC article. Review. No abstract available. - Choices--and uncertainties--for women with BRCA mutations.
Couzin J. Couzin J. Science. 2003 Oct 24;302(5645):592. doi: 10.1126/science.302.5645.592. Science. 2003. PMID: 14576419 No abstract available. - Breast cancer risks for BRCA1/2 carriers.
Wacholder S, Struewing JP, Hartge P, Greene MH, Tucker MA. Wacholder S, et al. Science. 2004 Dec 24;306(5705):2187-91; author reply 2187-91. Science. 2004. PMID: 15622558 No abstract available. - Concomitant BRCA1 and BRCA2 gene mutations in an Ashkenazi Jewish woman with primary breast and ovarian cancer.
Spannuth WA, Thaker PH, Sood AK. Spannuth WA, et al. Am J Obstet Gynecol. 2007 Apr;196(4):e6-9. doi: 10.1016/j.ajog.2007.01.026. Am J Obstet Gynecol. 2007. PMID: 17403394 - Familial breast and ovarian cancers.
Arai M, Utsunomiya J, Miki Y. Arai M, et al. Int J Clin Oncol. 2004 Aug;9(4):270-82. doi: 10.1007/s10147-004-0423-3. Int J Clin Oncol. 2004. PMID: 15375703 Review.
Cited by
- Two Missense Variants Detected in Breast Cancer Probands Preventing BRCA2-PALB2 Protein Interaction.
Caleca L, Catucci I, Figlioli G, De Cecco L, Pesaran T, Ward M, Volorio S, Falanga A, Marchetti M, Iascone M, Tondini C, Zambelli A, Azzollini J, Manoukian S, Radice P, Peterlongo P. Caleca L, et al. Front Oncol. 2018 Oct 25;8:480. doi: 10.3389/fonc.2018.00480. eCollection 2018. Front Oncol. 2018. PMID: 30410870 Free PMC article. - Pathogenesis and Potential Therapeutic Targets for Triple-Negative Breast Cancer.
Li CJ, Tzeng YT, Chiu YH, Lin HY, Hou MF, Chu PY. Li CJ, et al. Cancers (Basel). 2021 Jun 14;13(12):2978. doi: 10.3390/cancers13122978. Cancers (Basel). 2021. PMID: 34198652 Free PMC article. Review. - A Retrospective Exploration of the Impact of the 'Angelina Jolie Effect' on the Single State-Wide Familial Cancer Program in Perth, Western Australia.
Freedman R, Mountain H, Karina D, Schofield L. Freedman R, et al. J Genet Couns. 2017 Feb;26(1):52-62. doi: 10.1007/s10897-016-9982-5. Epub 2016 Jun 6. J Genet Couns. 2017. PMID: 27265404 - DNA repair prognostic index modelling reveals an essential role for base excision repair in influencing clinical outcomes in ER negative and triple negative breast cancers.
Abdel-Fatah TM, Arora A, Moseley PM, Perry C, Rakha EA, Green AR, Chan SY, Ellis IO, Madhusudan S. Abdel-Fatah TM, et al. Oncotarget. 2015 Sep 8;6(26):21964-78. doi: 10.18632/oncotarget.4157. Oncotarget. 2015. PMID: 26267318 Free PMC article. - Founder and Recurrent Mutations in BRCA1 and BRCA2 Genes in Latin American Countries: State of the Art and Literature Review.
Ossa CA, Torres D. Ossa CA, et al. Oncologist. 2016 Jul;21(7):832-9. doi: 10.1634/theoncologist.2015-0416. Epub 2016 Jun 10. Oncologist. 2016. PMID: 27286788 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous